The Current Diagnosis and Treatment of high-risk Patients With Chronic Primary and Secondary Mitral Valve Regurgitation

References

• Lung B , VahanianA. Epidemiology of valvular heart disease in the adult. Nat. Rev. Cardiol., 8(3), 162–172 (2011).
   PubMed Web of Science ®Google Scholar
• El Sabbagh A , ReddyY, NishimuraR. Mitral valve regurgitation in the contemporary era: Insights into diagnosis, management, and future directions. JACC, 11(4), 628–643 (2018).
   Google Scholar
• Marsit O , ClavelM-A, Côté-LarocheCet al. Attenuated mitral leaflet enlargement contributes to functional mitral regurgitation after myocardial infarction. J. Am. Coll. Cardiol., 75(4), 395–405 (2020).
   PubMed Web of Science ®Google Scholar
• Otto C , GaaschW, ManningW, YeonS. Clinical manifestations and diagnosis of chronic mitral regurgitation. UptoDate (2019).
   Google Scholar
• McCarthy K , RingL, RanaB. Anatomy of the mitral valve: understanding the mitral valve complex in mitral regurgitation. Euro J. Echocardio., 11(10), i3–i9 (2010).
   PubMed Web of Science ®Google Scholar
• Silbiger J . Anatomy, mechanics, and pathophysiology of the mitral annulus. Am. Heart J., 164(2), 163–176 (2012).
   PubMed Web of Science ®Google Scholar
• Freed L , LevyD, LevineRet al. Prevalence and clinical outcome of mitral-valve prolapse. N. Engl. J. Med., 341(1), 1–7 (1999).
   PubMed Web of Science ®Google Scholar
• Lawrie GM . Barlow disease: simple and complex. J. Thorac. Cardiovasc. Surg., 150(5), 1078–1081 (2015).
   PubMed Web of Science ®Google Scholar
• Gasser S , ReichenspurnerH, Girdauskas-GasserEet al. Genomic analysis in patients with myxomatous mitral valve prolapse: current state of knowledge. BMC Cardiovasc. Disorders, 18, 41 (2018).
   PubMed Web of Science ®Google Scholar
• Hjortnaes J , KeeganJ, BrunevalPet al. Comparative histopathological analysis of mitral valves in Barlow disease and fibroelastic deficiency. Semin. Thorac. Cardiovasc. Surg., 28(4), 757–767 (2016).
   PubMedGoogle Scholar
• Tsang W . Recent advances in understanding and managing mitral valve disease. F1000 Res., 8(F1000 Faculty 4 Rev), 1686 (2019).
   Google Scholar
• Matsumaru I , EishiK, HashizumeK, KawanoH, TsunetoA, HayashiT. Clinical and pathological features of degenerative mitral valve disease: billowing mitral leaflet versus fibroelastic deficiency. Ann. Thorac. Cardiovasc. Surg., 20(6), 987–994 (2014).
   PubMed Web of Science ®Google Scholar
• Anyanwu A , AdamsD. Etiologic classification of degenerative mitral valve disease: Barlow’s disease and fibroelastic deficiency. Semin. Thorac. Cardiovasc. Surg., 19(2), 90–96 (2007).
   PubMedGoogle Scholar
• Fornes P , HeudesD, FuzellierJFet al. Correlation between clinical and histologic patterns of degenerative mitral valve insufficiency: a histomorphometric study of 130 excised segments. Cardiovasc. Pathol., 8(2), 81–92 (1999).
   PubMed Web of Science ®Google Scholar
• Althunayyan A , PetersenSE, LloydG, BhattacharyyaS. Mitral valve prolapse. Expert Rev. Cardiovasc. Ther., 17(1), 43–51 (2019).
   PubMed Web of Science ®Google Scholar
• Wunderlich NC , BeigelR, RaderF, FrankeJ, SiegelR. Degenerative mitral regurgitation: assessment, physical examination, and imaging. Curr. Cardiol. Rep., 21(8), 85 (2019).
   PubMed Web of Science ®Google Scholar
• Maganti K , RigolinV, SaranoM, BonowR. Valvular heart disease: diagnosis and management. Mayo Clin. Proc., 85(5), 483–500 (2010).
   PubMed Web of Science ®Google Scholar
• van Wijngaarden S , AboutHiemstra Yet al. Regional left ventricular myocardial mechanics in degenerative myxomatous mitral valve disease a comparison between fibroelastic deficiency and Barlow’s disease. JACC Cardiovasc. Imaging, 11(9), 1362–1364 (2018).
   PubMed Web of Science ®Google Scholar
• Otto C , NishimuraR, BonowRet al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease. Circ., 143(5), e720e227 (2021).
   Web of Science ®Google Scholar
• Bonow R , O’GaraP, VadhwarVet al. 2020 Focus update of the 2017 ACC Expert consensus decision pathway on the management of mitral regurgitation. J. Am. Coll. Cardiol., 75(17), 2236–2266 (2020).
   PubMed Web of Science ®Google Scholar
• Baumgartner H , FalkV, BaxJet al. ESC/EACTS Guidelines for the management of valvular heart disease. Eur. Heart J., 38(36), 2739–2791 (2017).
   PubMed Web of Science ®Google Scholar
• Tribouilloy C , RusinaruD, SzymanskiCet al. Predicting left ventricular dysfunction after valve repair for mitral regurgitation due to leaflet prolapse: additive value of left ventricular end-systolic dimension to ejection fraction. Eur. J. Echocardiogr., 12(9), 702–710 (2011).
   PubMed Web of Science ®Google Scholar
• Johl M , MalhotraP, KehlD, RaderF, SiegelR. Natriuretic peptides in the evaluation and management of degenerative mitral regurgitation: a systematic review. Heart, 103(10), 738–744 (2017).
   PubMed Web of Science ®Google Scholar
• Baumgartner H , LungB, OttoC. Timing of intervention in asymptomatic patients with valvular heart disease. Eur. Heart J.ehaa485 (2020).
   Google Scholar
• Bonow R , CarabelloB, ChatterjeeKet al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. J. Am. Coll. Cardiol., 48(3), e1–148 (2006).
   PubMed Web of Science ®Google Scholar
• Kovalova S , NecasJ, MikulO. Discrimination between fibroelastic deficiency and Barlow disease using parameters of mitral annulus derived from real-time three-dimensional echocardiography. J. Echocardiogr., 11(3), 83–88 (2013).
   PubMedGoogle Scholar
• Uretsky S , ArgulianE, NarulaJ, WolffS. Use of cardiac magnetic resonance imaging in assessing mitral regurgitation: current evidence. J. Am. Coll. Cardiol., 71(5), 547–563 (2018).
   PubMed Web of Science ®Google Scholar
• Mehta N , KimJ, SidenJYet al. Utility of cardiac magnetic resonance for evaluation of mitral regurgitation prior to mitral valve surgery. J. Thorac. Dis., 9(Suppl. 4), S246–S256 (2017).
   PubMedGoogle Scholar
• Uretsky S , GillamL, LangRet al. Discordance between echocardiography and MRI in the assessment of mitral regurgitation severity: a prospective multicenter trial. J. Am. Coll. Cardiol., 65(11), 1078–1088 (2015).
   PubMed Web of Science ®Google Scholar
• lavel M , TribouilloyC, VanoverscheldeJet al. Association of B-type natriuretic peptide with survival in patients with degenerative mitral regurgitation. J. Am. Coll. Cardiol., 68(12), 1297–1307 (2016).
   PubMed Web of Science ®Google Scholar
• Ray S . Natriuretic peptides in heart valve disease. Heart, 92(9), 1194–1197 (2005).
   PubMed Web of Science ®Google Scholar
• Dini FL , FontaniveP, ContiU, AndreiniD, CabaniE, DeTommasi S. Plasma N-terminal protype-B natriuretic peptide levels in risk assessment of patients with mitral regurgitation secondary to ischemic and nonischemic dilated cardiomyopathy. Am. Heart J., 155(6), 1121–1127 (2008).
   PubMed Web of Science ®Google Scholar
• Enriquez-Sarano M , AkinsC, VahanianA. Mitral regurgitation. Lancet, 373(9672), 1382–1394 (2009).
   PubMed Web of Science ®Google Scholar
• Nishimura R , OttoC, BonowRet al. AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circ, 135(25), e1159–e1195 (2017).
   PubMed Web of Science ®Google Scholar
• Ahmed M , AbanI, LloydS, GuptaHet al. A randomized controlled phase IIb trial of beta(1)-receptor blockade for chronic degenerative mitral regurgitation. J. Am. Coll. Cardiol., 60(9), 833–838 (2012).
   PubMed Web of Science ®Google Scholar
• Varadarajan P , JoshiN, AppelD, DuvvuriL, PaiR. Effect of beta-blocker therapy on survival in patients with severe mitral regurgitation and normal left ventricular ejection fraction. Am. J. Cardiol., 102(5), 611–615 (2008).
   PubMed Web of Science ®Google Scholar
• Carabello B . Ischemic mitral regurgitation and ventricular remodeling. J. Am. Coll. Cardiol., 43(10), 384–5 (2004).
   PubMed Web of Science ®Google Scholar
• Gaasch W , OttoC, AldeaG, VerrierE, YeonS. Surgical procedures for severe chronic mitral regurgitation. UptoDate (2018).
   Google Scholar
• Cox J . Intraoperative options for treating atrial fibrillation associated with mitral valve disease. J. Thorac. Cardiovasc. Surg., 122(2), 212–215 (2001).
   PubMed Web of Science ®Google Scholar
• Glower D , KarS, TrentoAet al. Percutaneous mitral valve repair for mitral regurgitation in high-risk patients. results of the EVEREST II study. J. Am. Coll. Cardiol., 644(2), 172–181 (2014).
   Google Scholar
• Feldman T , KarS, ElmariahSet al. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J. Am. Coll. Cardiol., 66, 2844–2854 (2015).
   PubMed Web of Science ®Google Scholar
• Adams D , AnyanwuA, RahmanianPet al. Large annuloplasty rings facilitate mitral valve repair in Barlow’s disease. Ann. Thorac. Surg., 82, 2096–2100 (2006).
   PubMed Web of Science ®Google Scholar
• Enriquez-Sarano M , AkinsC, VahanianA. Mitral regurgitation. Lancet, 373(9672), 1382–1394 (2009).
   PubMed Web of Science ®Google Scholar
• David T , IvanovJ, ArmstrongS, RakowskiH. Late outcomes of mitral valve repair for floppy valves: Implications for asymptomatic patients. J. Thorac. Cardiovasc. Surg., 125(5), 1143–1152 (2003).
   PubMed Web of Science ®Google Scholar
• Kang D , KimJ, RimJet al. Comparison of early surgery versus conventional treatment in asymptomatic severe mitral regurgitation. Circ., 119(6), 797–804 (2009).
   PubMed Web of Science ®Google Scholar
• Tibayan F , RodriguezF, ZasioMet al. Geometric distortions of the mitral valvular-ventricular complex in chronic ischemic mitral regurgitation. Circ., 108(Suppl. 1), II-116–II-121 (2003).
   Google Scholar
• Deferm S , BertrandP, VerbruggeFet al. Atrial functional mitral regurgitation: JACC review topic of the week. J. Am. Coll. Cardiol., 73(19), 2465–2476 (2019).
   PubMed Web of Science ®Google Scholar
• Bursi F , Enriquez-SaranoM, JacobsenS, RogerV. Mitral regurgitation after myocardial infarction: a review. Am. J. Med., 119(2), 103–112 (2006).
   PubMed Web of Science ®Google Scholar
• Kwan J , ShiotaT, AglerAet al. Geometric differences of the mitral apparatus between ischemic and dilated cardiomyopathy with significant mitral regurgitation: real-time three dimensional echocardiography study. Circ., 107(8), 1135–1140 (2003).
   PubMed Web of Science ®Google Scholar
• Zoghbi W , AdamsD, BonowRet al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J. Am. Soc. Echocard., 30(4), 303–371 (2017).
   PubMed Web of Science ®Google Scholar
• Piérard L , LancellottiP. The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema. N. Engl. J. Med., 351(16), 1627–1634 (2004).
   PubMed Web of Science ®Google Scholar
• Stolfo D , MerloM, PinamontiBet al. Early improvement of functional mitral regurgitation in patients with idiopathic dilated cardiomyopathy. Am. J. Cardiol., 115(8), 1137–1143 (2015).
   PubMed Web of Science ®Google Scholar
• Karaca O , AvciA, GulerGet al. Tenting area reflects disease severity and prognosis in patients with non-ischaemic dilated cardiomyopathy and functional mitral regurgitation. Euro J. Heart Failure, 13, 284–291 (2011).
   PubMed Web of Science ®Google Scholar
• Agricola E , OppizziM, GalderisiMet al. Role of regional mechanical dyssynchrony as a determinant of functional mitral regurgitation in patients with left ventricular systolic dysfunction. Heart, 92(10), 1390–1395 (2006).
   PubMed Web of Science ®Google Scholar
• Ito K , AbeY, TakahashiYet al. Mechanism of atrial functional mitral regurgitation in patients with atrial fibrillation: a study using three dimensional transesophageal echocardiography. J. Cardiol., 70(6), 584–590 (2017).
   PubMed Web of Science ®Google Scholar
• Nishimura R , VahanianA, EleidM, MackM. Mitral valve disease--current management and future challenges. Lancet, 387(10025), 1324–1334 (2016).
   PubMed Web of Science ®Google Scholar
• Patel J , BorgesonD, BarnesM, RihalC, DalyR, RedfieldM. Mitral regurgitation in patients with advanced systolic heart failure. J. Card. Fail., 10(4), 285–291 (2004).
   PubMed Web of Science ®Google Scholar
• Hassan A , AlgowharyM, KishkAet al. Cardiac magnetic resonance assessment of mitral regurgitation severity appears better than echocardiographic imaging. Int. J. Cardiovasc. Imaging, 36(5), 889–897 (2020).
   PubMed Web of Science ®Google Scholar
• Sutton T , StewartR, GerberIet al. Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J. Am. Coll. Cardiol., 41(12), 2280–2287 (2003).
   PubMed Web of Science ®Google Scholar
• Detaint D , Messika-ZeitounD, AvierinosJ-Fet al. B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome. Circ, 111, 2391–2397 (2005).
   PubMed Web of Science ®Google Scholar
• Rossi A , DiniF, FaggianoPet al. Independent prognostic value of functional mitral regurgitation in patients with heart failure: a quantitative analysis of 1256 patients with ischaemic and nonischaemic dilated cardiomyopathy. Heart, 97(20), 1675–1680 (2011).
   PubMed Web of Science ®Google Scholar
• Goel S , BajajN, AggarwalBet al. Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet need. J. Am. Coll. Cardiol., 63(2), 185–186 (2014).
   PubMed Web of Science ®Google Scholar
• Maddox T , JanuzziJ, AllenLet al. 2021 update to the 2017 ACC Expert Consensus Decision Pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction. J. Am. Coll. Cardiol., 77(6), 772–810 (2021).
   PubMed Web of Science ®Google Scholar
• Capomolla S , FeboO, GnemmiMet al. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Am. Heart J., 139(4), 596–608 (2000).
   PubMed Web of Science ®Google Scholar
• Gertz Z , RainaA, SaghyLet al. Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control. J. Am. Coll. Cardiol., 58(14), 1474–1481 (2011).
   PubMed Web of Science ®Google Scholar
• Breithardt O , SinhaA, SchwammenthalEet al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J. Am. Coll. Cardiol., 41(5), 765–770 (2003).
   PubMed Web of Science ®Google Scholar
• Kang D , ParkS, ShinSet al. Angiotensin receptor neprilysin inhibitor for functional mitral regurgitation: PRIME study. Circulation, 139(11), 1354–1365 (2019).
   PubMed Web of Science ®Google Scholar
• Martens P , BeliënH, DupontM, VandervoortP, MullensW. The reverse remodeling response to sacubitril/valsartan therapy in heart failure with reduced ejection fraction. Cardiovasc. Ther., 36, e12435 (2018).
   PubMed Web of Science ®Google Scholar
• Gaasch W , OttoC, YeonS. Management of chronic primary mitral regurgitation. UptoDate(2020).
   Google Scholar
• Aklog L , FilsoufiF, FloresKQet al. Does coronary artery bypass grafting alone correct moderate ischemic mitral regurgitation? Circ., 104(Suppl. 1), I68–75 (2001).
   PubMedGoogle Scholar
• Penicka M , LinkovaH, LangOet al. Predictors of improvement of unrepaired moderate ischemic mitral regurgitation in patients undergoing elective isolated coronary artery bypass graft surgery. Circ, 120(15), 1474–1481 (2009).
   PubMed Web of Science ®Google Scholar
• Michler R , SmithP, ParidesMet al. Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation. N. Engl. J. Med., 374(20), 1932–1941 (2016).
   PubMed Web of Science ®Google Scholar
• Goldstein D , MoskowitzA, GelijnsAet al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N. Engl. J. Med., 374(20), 344–353 (2016).
   PubMed Web of Science ®Google Scholar
• Kongsaerepong V , ShiotaM, GillinovAet al. Echocardiographic predictors of successful versus unsuccessful mitral valve repair in ischemic mitral regurgitation. Am. J. Cardiol., 98(4), 504–508 (2006).
   PubMed Web of Science ®Google Scholar
• Acker M , ParidesM, PerraultLet al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N. Engl. J. Med., 370(1), 23–32 (2014).
   PubMed Web of Science ®Google Scholar
• Acker M , BollingS, SheminRet al. Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial. J. Thorac. Cardiovasc. Surg., 132(3), 568–577 (2006).
   PubMedGoogle Scholar
• McGee E , GillinovA, BlackstoneEet al. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J. Thorac. Cardiovasc. Surg., 128(6), 916–924 (2004).
   PubMed Web of Science ®Google Scholar
• Lee A , AckerM, KuboSet al. Mechanisms of recurrent functional mitral regurgitation after mitral valve repair in nonischemic dilated cardiomyopathy: importance of distal anterior leaflet tethering. Circ., 119(19), 2606–2614 (2009).
   PubMed Web of Science ®Google Scholar
• Wu A , AaronsonK, BollingS, PaganiF, WelchK, KoellingT. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J. Am. Coll. Cardiol., 45(3), 381–387 (2005).
   PubMed Web of Science ®Google Scholar
• Bonow R , O’GaraAdams Det al. Operator and Institutional recommendations and requirements for transcatheter mitral valve intervention: a joint report of the American Association for Thoracic Surgery, the American College of Cardiology, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J. Am. Coll. Cardiol., 76(1), 96–117 (2020).
   PubMed Web of Science ®Google Scholar
• Stone G , LindenfeldJ, AbrahamWet al. Transcatheter mitral-valve repair in patients with heart failure. N. Engl. J. Med., 379(24), 2307–2318 (2018).
   PubMed Web of Science ®Google Scholar
• Mack M , LindenfeldJ, AbrahamWet al. 3-year outcomes of transcatheter mitral valve repair in patients with heart failure. J. Am. Coll. Cardiol., 77, 1029–1040 (2021).
   PubMed Web of Science ®Google Scholar
• Obadia J , Messika-ZeitounD, LeurentGet al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N. Engl. J. Med., 379(24), 2297–2306 (2018).
   PubMed Web of Science ®Google Scholar
• Stone G , MackM. Treatment of mitral regurgitation: cut, clip or medicate?EuroIntervention, 14(17), 1710–1712 (2019).
   PubMed Web of Science ®Google Scholar
• Grinberg D , DonalE, ObadiaJ-F. What do MITRA-FR and COAPT teach us about the percutaneous treatment of secondary mitral regurgitation?EuroIntervention, 14(17), 1713–1715 (2019).
   PubMed Web of Science ®Google Scholar
• Grayburn P , SanninoA, PackerM. Proportionate and disproportionate functional mitral regurgitation: a new conceptual framework that reconciles the results of the MITRA-FR and COAPT trials. JACC Cardiovasc. Imaging, 12(2), 353–362 (2019).
   PubMed Web of Science ®Google Scholar
• Messika-Zeitoun D , LungB, ArmoiryXet al. Impact of mitral regurgitation severity and left ventricular remodeling on outcome after mitraclip implantation. results from the Mitra-FR trial. JACC Cardiovasc Imaging S1936-878X(20)30645-8 (2020).
   Web of Science ®Google Scholar
• A Clinical Evaluation of the Safety and Effectiveness of the MitraClip System in the Treatment of Clinically Significant Functional Mitral Regurgitation (Reshape-HF2). ClinicalTrials.gov Websitehttps://clinicaltrials.gov/ct2/show/NCT02444338
   Google Scholar
• Webb J , HenseyM, SzerlipMet al. One-year outcomes for transcatheter repair in patients with mitral regurgitation from the CLASP study. JACC Cardiovasc. Interv., 13(20), 2344–2357 (2020).
   PubMed Web of Science ®Google Scholar
• Miller M , ThouraniVH, WhisenantB. The Cardioband transcatheter annular reduction system. Ann. Cardiothorac. Surg., 7(6), 741–747 (2018).
   PubMed Web of Science ®Google Scholar
• Rogers J , BoydW, SmithT, BollingS. Transcatheter mitral valve direct annuloplasty with the Millipede IRIS ring. Interv. Cardiol. Clin., 8(3), 261–267 (2019).
   PubMedGoogle Scholar
• Witte K , LipieckiJ, SiminiakTet al. The REDUCE FMR trial: a randomized sham-controlled study of percutaneous mitral annuloplasty in functional mitral regurgitation. JACC Heart Fail., 7(11), 945–955 (2019).
   PubMed Web of Science ®Google Scholar
• Hensey M , BrownR, LalSet al. Transcatheter mitral valve replacement. JACC Cardiovasc. Intervent., 14(5), 489–500 (2021).
   PubMed Web of Science ®Google Scholar
• Vogelhuber J , WeberM, SinningM, NickenigG. Kathetergeführter Mitralklappenersatz: aktueller Stand [Transcatheter mitral valve replacement: current status]. Herz, 44(7), 602–610 (2019).
   PubMed Web of Science ®Google Scholar
• Ghair F , OmranJ. Percutaneous mitral valve therapies: the old, current, and future. expert analysis. J. Am. Coll. Cardiol., https://www.acc.org/latest-in-cardiology/articles/2020/07/31/08/28/percutaneous-mitral-valve-therapies
   Google Scholar
• Abbott. Tendyne™. https://www.cardiovascular.abbott/int/en/hcp/products/structural-heart/tendyne-mitral-valve.html
   Google Scholar
• Muller D , FarivarR, JanszPet al. Tendyne Global Feasibility Trial Investigators . Transcatheter mitral valve replacement for patients with symptomatic mitral regurgitation: a global feasibility trial. J. Am. Coll. Cardiol., 69(4), 381–391 (2017).
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov . Expanded Clinical Study of the Tendyne Mitral Valve System. Clinicaltrials.gov/ct2/show/NCT02321514
   Google Scholar
• ClinicalTrials.gov . Feasibility study of the Tendyne mitral valve system for use in subjects with mitral annular calcification. https://clinicaltrials.gov/ct2/show/NCT03539458
   Google Scholar
• Bapat V , RajagopalV, MeduriCet al. Early experience with new transcatheter mitral valve replacement. J. Am. Coll. Cardiol., 71(1), 12–21 (2018).
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov . Transcatheter Mitral Valve Replacement with the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation (APOLLO). https://clinicaltrials. gov/ct2/show/NCT03242642
   Google Scholar
• Mahjoub H , MathieuP, LaroseEet al. Determinants of aortic bioprosthetic valve calcification assessed by multidetector CT. Heart, 101(6), 472–474 (2015).
   PubMed Web of Science ®Google Scholar
• Chikwe J , ChiangY, EgorovaNet al. Survival and outcomes following bioprosthetic vs mechanical mitral valve replacement in patients aged 50 to 69 years. JAMA, 313(14), 1435–1442 (2015).
   PubMed Web of Science ®Google Scholar
• Vohra H , WhistanceR, RoubelakisAet al. Outcome after redo-mitral valve replacement in adult patients: a 10-year single-centre experience. Interact. Cardiovasc. Thorac. Surg., 14(5), 575–579 (2012).
   PubMed Web of Science ®Google Scholar
• Koziarz A , MakhdoumA, ButanyJ, OuzounianM, ChungJ. Modes of bioprosthetic valve failure: a narrative review. Curr. Opin. Cardiol., 35(2), 123–132 (2020).
   PubMed Web of Science ®Google Scholar
• Mehaffey H , HawkinsR, SchubertSet al. Contemporary outcomes in reoperative mitral valve surgery. Heart, 104(8), 652–656 (2018).
   PubMed Web of Science ®Google Scholar
• Balsam L , GrossiE, GreenhouseDet al. Reoperative valve surgery in the elderly: predictors of risk and long-term survival. Ann. Thorac. Surg., 90(4), 1195–1200 (2010).
   PubMed Web of Science ®Google Scholar
• Regueiro A , GranadaJ, DagenaisF, Rodes-CabauJ. Transcatheter mitral valve replacement insights from early clinical experience and future challenges. J. Am. Coll. Cardiol., 69(17), 2175–2192 (2017).
   PubMed Web of Science ®Google Scholar
• Dvir D . Transcatheter mitral valve-in-valve and valve-in-ring implantations. Presented at: Euro-PCR 2015 (2015). https://eurointervention.pcronline.com/article/transcatheter-mitral-valve-in-valve-valve-in-ring-implantations-for-degenerative-post-surgical-valves-results-from-the-global-valve-in-valve-registry
   Google Scholar
• Yoon S-H , WhisenantB, BleizifferS. Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Euro. Heart J., 40(5), 441–451 (2019).
   PubMed Web of Science ®Google Scholar
• Urena M , BrochetE, LecomteMet al. Clinical and haemodynamic outcomes of balloon-expandable transcatheter mitral valve implantation: a 7-year experience. Euro. Heart J., 39(28), 2679–2689 (2018).
   PubMed Web of Science ®Google Scholar
• Takagi H , HariY, KawaiN. Ando T for the ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. A meta-analysis of valve-in-valve and valve-in-ring transcatheter mitral valve implantation. J. Interv. Cardiol., 31(6), 899–906 (2018).
   PubMed Web of Science ®Google Scholar
• Whisenant B , KapadiaS, EleidMet al. One-year outcomes of mitral valve-in-valve using the SAPIEN 3 transcatheter heart valve. JAMA Cardiol., 5(11), 1245–1252 (2020).
   PubMed Web of Science ®Google Scholar
• The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves). (MITRAL-II). ClinicalTrials.gov Websitehttps://clinicaltrials.Gov
   Google Scholar